NetworkNewsWire Announces Publication on the Use of …

NEW YORK, Dec. 07, 2017 (GLOBE NEWSWIRE) — via NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring InMed Pharmaceuticals, Inc. (CSE:IN) (OTCQB:IMLFF), a preclinical stage biopharmaceutical company specializing in the research and development of novel, cannabinoid-based prescription drug therapies utilizing novel drug delivery systems.

The publication, titled, “Advanced Biosynthesis Setting New Standards for Cannabinoid-based Pain Management,” reviews InMed’s cannabinoid manufacturing process and its potential in pain management.

To view the full publication, visit: https://www.networknewswire.com/advanced-biosynthesis-setting-new-standards-cannabinoid-based-pain-management

“Other biopharmaceutical companies may produce cannabinoids in the laboratory using

...read more at https://globenewswire.com/news-release/2017/12/07/1247469/0/en/NetworkNewsWire-Announces-Publication-on-the-Use-of-Cannabinoids-for-Pain-Management-and-other-Medical-Applications.html

by

Leave a Reply